$680 Million is the total value of VR Adviser, LLC's 25 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 72.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | TRILLIUM THERAPEUTICS INC | $59,428,000 | -42.0% | 4,040,000 | -43.9% | 8.74% | -56.4% | |
| SURF | Sell | SURFACE ONCOLOGY INC | $13,332,000 | -50.2% | 1,442,895 | -62.8% | 1.96% | -62.6% |
| MTCR | Sell | METACRINE INC | $5,452,000 | -53.3% | 693,673 | -39.3% | 0.80% | -64.9% |
| MDNA | Exit | MEDICENNA THERAPEUTICS CORP | $0 | – | -92,453 | -100.0% | -0.08% | – |
| FSDC | Exit | FS DEVELOPMENT CORP-A | $0 | – | -500,000 | -100.0% | -1.10% | – |
| UMRX | Exit | UNUM THERAPEUTICS INC | $0 | – | -4,355,273 | -100.0% | -1.99% | – |
| ALXO | Exit | ALX ONCOLOGY HOLDINGS INC | $0 | – | -300,000 | -100.0% | -2.22% | – |
| MRNS | Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -1,192,883 | -100.0% | -3.00% | – |
| IMV | Exit | IMV INC | $0 | – | -4,000,000 | -100.0% | -3.47% | – |
| CRDF | Exit | CARDIFF ONCOLOGY INC | $0 | – | -1,271,985 | -100.0% | -3.53% | – |
| HGEN | Exit | HUMANIGEN INC | $0 | – | -2,332,516 | -100.0% | -4.86% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 12 | Q3 2023 | 12.7% |
| VIRIDIAN THERAPEUTICS INC | 12 | Q3 2023 | 13.4% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.3% |
| RELMADA THERAPEUTICS INC | 11 | Q3 2022 | 9.9% |
| GH RESEARCH PLC | 10 | Q3 2023 | 6.7% |
| ALTIMMUNE INC | 9 | Q3 2022 | 11.6% |
| MARINUS PHARMACEUTICALS INC | 9 | Q4 2022 | 5.7% |
| CELLDEX THERAPEUTICS INC | 9 | Q3 2022 | 7.6% |
| AFFIMED N V | 8 | Q3 2023 | 1.1% |
| INSTIL BIO INC | 7 | Q3 2022 | 18.7% |
View VR Adviser, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View VR Adviser, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.